Drugs / Polyphenol whole tumor cell vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06878612 | Apr 2025 → Aug 2026 overdue | cancer or benign tumor | Xingchen Peng | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Polyphenol whole tumor cell vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06878612 ↗ |
| Modality | Vaccine | “Whole tumor cell vaccine (TCV) is a classic individualized tumor immunotherapy” NCT06878612 ↗ |